TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

RNS Number : 1298M

ReNeuron Group plc

21 August 2013

 



21 August 2013

AIM: RENE

ReNeuron Group plc

(the "Company")

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:			ReNeuron Group plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights				√
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation:		Merlin General Partner II Limited as a General Partner of The Merlin Biosciences Fund LP and a Managing Partner of The Merlin Biosciences Fund GbR
4. Full name of shareholder(s)  (if different from 3.):		-
5. Date of the transaction and date on which the threshold is crossed or reached:		19 August 2013
6. Date on which issuer notified:		19 August 2013
7. Threshold(s) that is/are crossed or reached:		From 9% to below 1%

8. Notified details:

A: Voting rights attached to shares

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of  voting rights

Direct

Direct

Indirect

Direct

Indirect

ORDINARY SHARES Of 1 pence each

73,844,250

73,844,250

16,244,250

16,244,250

0.91%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

16,244,250

0.91%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
Merlin General Partner II Limited acts as a General Partner of The Merlin Biosciences Fund LP and a Managing Partner of The Merlin Biosciences Fund GbR
Proxy Voting:
10. Name of the proxy holder:		N/A
11. Number of voting rights proxy holder will cease to hold:		N/A
12. Date on which proxy holder will cease to hold voting rights:		N/A
13. Additional information:	Position calculated on issued capital of 1,788,827,700 (Placement by company on 09 August 2013 of 1,014,000,000 new Ordinary shares). Sale of 57,600,000 shares by Merlin Biosciences Fund LP and GbR on 19 August 2013
14. Contact name:	Shafia Zahoor
15. Contact telephone number:	020-7887-7646

 

END

 

 

HOLLLFVETSIIFIV